nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP1A2—Pentoxifylline—systemic scleroderma	0.144	0.222	CbGbCtD
Methimazole—CYP1A2—Leflunomide—systemic scleroderma	0.137	0.212	CbGbCtD
Methimazole—CYP2C9—Leflunomide—systemic scleroderma	0.124	0.191	CbGbCtD
Methimazole—CYP2D6—Captopril—systemic scleroderma	0.0887	0.137	CbGbCtD
Methimazole—CYP2C19—Prednisone—systemic scleroderma	0.0734	0.114	CbGbCtD
Methimazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0444	0.0687	CbGbCtD
Methimazole—CYP3A4—Prednisone—systemic scleroderma	0.0355	0.0549	CbGbCtD
Methimazole—CYP2C9—cardial valve—systemic scleroderma	0.0179	0.491	CbGeAlD
Methimazole—Nephritis—Captopril—systemic scleroderma	0.0139	0.0438	CcSEcCtD
Methimazole—Pigmentation skin—Prednisone—systemic scleroderma	0.0109	0.0345	CcSEcCtD
Methimazole—Nephritis—Mycophenolate mofetil—systemic scleroderma	0.00862	0.0272	CcSEcCtD
Methimazole—Pigmentation disorder—Prednisone—systemic scleroderma	0.00598	0.0189	CcSEcCtD
Methimazole—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.00588	0.0185	CcSEcCtD
Methimazole—Ageusia—Captopril—systemic scleroderma	0.00586	0.0185	CcSEcCtD
Methimazole—Neuritis—Leflunomide—systemic scleroderma	0.00524	0.0165	CcSEcCtD
Methimazole—TPO—digestive system—systemic scleroderma	0.00427	0.117	CbGeAlD
Methimazole—TPO—tendon—systemic scleroderma	0.00406	0.112	CbGeAlD
Methimazole—Lymphadenopathy—Captopril—systemic scleroderma	0.00404	0.0127	CcSEcCtD
Methimazole—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00389	0.0123	CcSEcCtD
Methimazole—Ageusia—Mycophenolate mofetil—systemic scleroderma	0.00364	0.0115	CcSEcCtD
Methimazole—Drowsiness—Pentoxifylline—systemic scleroderma	0.0035	0.011	CcSEcCtD
Methimazole—Jaundice—Pentoxifylline—systemic scleroderma	0.00342	0.0108	CcSEcCtD
Methimazole—Lymphadenopathy—Leflunomide—systemic scleroderma	0.00333	0.0105	CcSEcCtD
Methimazole—Lymphadenopathy—Mycophenolic acid—systemic scleroderma	0.00318	0.01	CcSEcCtD
Methimazole—Hepatitis—Pentoxifylline—systemic scleroderma	0.00315	0.00992	CcSEcCtD
Methimazole—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00277	0.00872	CcSEcCtD
Methimazole—Neuritis—Prednisone—systemic scleroderma	0.00267	0.00843	CcSEcCtD
Methimazole—Jaundice—Captopril—systemic scleroderma	0.00259	0.00816	CcSEcCtD
Methimazole—Lymphadenopathy—Mycophenolate mofetil—systemic scleroderma	0.00251	0.0079	CcSEcCtD
Methimazole—Agranulocytosis—Captopril—systemic scleroderma	0.00248	0.00781	CcSEcCtD
Methimazole—Leukopenia—Pentoxifylline—systemic scleroderma	0.00245	0.00773	CcSEcCtD
Methimazole—Hepatitis—Captopril—systemic scleroderma	0.00238	0.00751	CcSEcCtD
Methimazole—Myalgia—Pentoxifylline—systemic scleroderma	0.00233	0.00735	CcSEcCtD
Methimazole—Oedema—Pentoxifylline—systemic scleroderma	0.00223	0.00704	CcSEcCtD
Methimazole—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00219	0.0069	CcSEcCtD
Methimazole—Agranulocytosis—Azathioprine—systemic scleroderma	0.00216	0.00682	CcSEcCtD
Methimazole—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.00215	0.00676	CcSEcCtD
Methimazole—Jaundice—Leflunomide—systemic scleroderma	0.00213	0.00672	CcSEcCtD
Methimazole—Alopecia—Captopril—systemic scleroderma	0.00211	0.00664	CcSEcCtD
Methimazole—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00205	0.00645	CcSEcCtD
Methimazole—Agranulocytosis—Leflunomide—systemic scleroderma	0.00204	0.00644	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00204	0.00642	CcSEcCtD
Methimazole—Jaundice—Mycophenolic acid—systemic scleroderma	0.00204	0.00642	CcSEcCtD
Methimazole—Myalgia—Mometasone—systemic scleroderma	0.00201	0.00634	CcSEcCtD
Methimazole—Arthralgia—Mometasone—systemic scleroderma	0.00201	0.00634	CcSEcCtD
Methimazole—Somnolence—Pentoxifylline—systemic scleroderma	0.00199	0.00626	CcSEcCtD
Methimazole—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00197	0.0062	CcSEcCtD
Methimazole—Hepatitis—Leflunomide—systemic scleroderma	0.00196	0.00619	CcSEcCtD
Methimazole—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00195	0.00614	CcSEcCtD
Methimazole—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00187	0.00591	CcSEcCtD
Methimazole—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00184	0.00581	CcSEcCtD
Methimazole—Alopecia—Azathioprine—systemic scleroderma	0.00184	0.0058	CcSEcCtD
Methimazole—Jaundice—Lisinopril—systemic scleroderma	0.00183	0.00578	CcSEcCtD
Methimazole—Urticaria—Pentoxifylline—systemic scleroderma	0.00178	0.0056	CcSEcCtD
Methimazole—Arthralgia—Captopril—systemic scleroderma	0.00177	0.00557	CcSEcCtD
Methimazole—Myalgia—Captopril—systemic scleroderma	0.00177	0.00557	CcSEcCtD
Methimazole—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00177	0.00557	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00176	0.00554	CcSEcCtD
Methimazole—Agranulocytosis—Lisinopril—systemic scleroderma	0.00176	0.00553	CcSEcCtD
Methimazole—Alopecia—Leflunomide—systemic scleroderma	0.00174	0.00547	CcSEcCtD
Methimazole—Paraesthesia—Mometasone—systemic scleroderma	0.00173	0.00546	CcSEcCtD
Methimazole—Dyspepsia—Mometasone—systemic scleroderma	0.0017	0.00535	CcSEcCtD
Methimazole—Hepatitis—Lisinopril—systemic scleroderma	0.00169	0.00532	CcSEcCtD
Methimazole—Thrombocytopenia—Captopril—systemic scleroderma	0.00166	0.00523	CcSEcCtD
Methimazole—Alopecia—Mycophenolic acid—systemic scleroderma	0.00166	0.00522	CcSEcCtD
Methimazole—Leukopenia—Azathioprine—systemic scleroderma	0.00162	0.00511	CcSEcCtD
Methimazole—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00509	CcSEcCtD
Methimazole—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00506	CcSEcCtD
Methimazole—Pruritus—Pentoxifylline—systemic scleroderma	0.00158	0.00498	CcSEcCtD
Methimazole—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00157	0.00494	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00154	0.00486	CcSEcCtD
Methimazole—Myalgia—Azathioprine—systemic scleroderma	0.00154	0.00486	CcSEcCtD
Methimazole—Arthralgia—Azathioprine—systemic scleroderma	0.00154	0.00486	CcSEcCtD
Methimazole—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00485	CcSEcCtD
Methimazole—Vertigo—Leflunomide—systemic scleroderma	0.00154	0.00484	CcSEcCtD
Methimazole—Leukopenia—Leflunomide—systemic scleroderma	0.00153	0.00483	CcSEcCtD
Methimazole—Body temperature increased—Mometasone—systemic scleroderma	0.00152	0.0048	CcSEcCtD
Methimazole—Paraesthesia—Captopril—systemic scleroderma	0.00152	0.00479	CcSEcCtD
Methimazole—Somnolence—Captopril—systemic scleroderma	0.00151	0.00475	CcSEcCtD
Methimazole—Alopecia—Lisinopril—systemic scleroderma	0.00149	0.0047	CcSEcCtD
Methimazole—Dyspepsia—Captopril—systemic scleroderma	0.00149	0.0047	CcSEcCtD
Methimazole—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00466	CcSEcCtD
Methimazole—Vertigo—Mycophenolic acid—systemic scleroderma	0.00147	0.00462	CcSEcCtD
Methimazole—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00146	0.0046	CcSEcCtD
Methimazole—Arthralgia—Leflunomide—systemic scleroderma	0.00146	0.00459	CcSEcCtD
Methimazole—Myalgia—Leflunomide—systemic scleroderma	0.00146	0.00459	CcSEcCtD
Methimazole—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00145	0.00456	CcSEcCtD
Methimazole—Vomiting—Pentoxifylline—systemic scleroderma	0.00142	0.00448	CcSEcCtD
Methimazole—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00142	0.00448	CcSEcCtD
Methimazole—Rash—Pentoxifylline—systemic scleroderma	0.00141	0.00444	CcSEcCtD
Methimazole—Dermatitis—Pentoxifylline—systemic scleroderma	0.00141	0.00444	CcSEcCtD
Methimazole—Headache—Pentoxifylline—systemic scleroderma	0.0014	0.00441	CcSEcCtD
Methimazole—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00139	0.00438	CcSEcCtD
Methimazole—Myalgia—Mycophenolic acid—systemic scleroderma	0.00139	0.00438	CcSEcCtD
Methimazole—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00137	0.00431	CcSEcCtD
Methimazole—Pruritus—Mometasone—systemic scleroderma	0.00136	0.0043	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00135	0.00424	CcSEcCtD
Methimazole—Body temperature increased—Captopril—systemic scleroderma	0.00134	0.00422	CcSEcCtD
Methimazole—Oedema—Mycophenolic acid—systemic scleroderma	0.00133	0.0042	CcSEcCtD
Methimazole—Nausea—Pentoxifylline—systemic scleroderma	0.00133	0.00418	CcSEcCtD
Methimazole—Vertigo—Lisinopril—systemic scleroderma	0.00132	0.00416	CcSEcCtD
Methimazole—Leukopenia—Lisinopril—systemic scleroderma	0.00132	0.00415	CcSEcCtD
Methimazole—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00412	CcSEcCtD
Methimazole—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.0013	0.00411	CcSEcCtD
Methimazole—CYP2A6—lung—systemic scleroderma	0.0013	0.0356	CbGeAlD
Methimazole—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00127	0.00401	CcSEcCtD
Methimazole—Paraesthesia—Leflunomide—systemic scleroderma	0.00125	0.00395	CcSEcCtD
Methimazole—Arthralgia—Lisinopril—systemic scleroderma	0.00125	0.00394	CcSEcCtD
Methimazole—Myalgia—Lisinopril—systemic scleroderma	0.00125	0.00394	CcSEcCtD
Methimazole—Dyspepsia—Leflunomide—systemic scleroderma	0.00123	0.00387	CcSEcCtD
Methimazole—Vomiting—Mometasone—systemic scleroderma	0.00123	0.00386	CcSEcCtD
Methimazole—Rash—Mometasone—systemic scleroderma	0.00122	0.00383	CcSEcCtD
Methimazole—Dermatitis—Mometasone—systemic scleroderma	0.00121	0.00383	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00121	0.00382	CcSEcCtD
Methimazole—Headache—Mometasone—systemic scleroderma	0.00121	0.00381	CcSEcCtD
Methimazole—Oedema—Lisinopril—systemic scleroderma	0.0012	0.00378	CcSEcCtD
Methimazole—Pruritus—Captopril—systemic scleroderma	0.0012	0.00378	CcSEcCtD
Methimazole—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.0012	0.00377	CcSEcCtD
Methimazole—Somnolence—Mycophenolic acid—systemic scleroderma	0.00118	0.00373	CcSEcCtD
Methimazole—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00117	0.0037	CcSEcCtD
Methimazole—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00117	0.00369	CcSEcCtD
Methimazole—Body temperature increased—Azathioprine—systemic scleroderma	0.00117	0.00368	CcSEcCtD
Methimazole—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00365	CcSEcCtD
Methimazole—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00363	CcSEcCtD
Methimazole—Nausea—Mometasone—systemic scleroderma	0.00115	0.00361	CcSEcCtD
Methimazole—Urticaria—Leflunomide—systemic scleroderma	0.00111	0.0035	CcSEcCtD
Methimazole—Body temperature increased—Leflunomide—systemic scleroderma	0.0011	0.00348	CcSEcCtD
Methimazole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00346	CcSEcCtD
Methimazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00346	CcSEcCtD
Methimazole—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00109	0.00345	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00109	0.00344	CcSEcCtD
Methimazole—Paraesthesia—Lisinopril—systemic scleroderma	0.00108	0.00339	CcSEcCtD
Methimazole—Vomiting—Captopril—systemic scleroderma	0.00108	0.00339	CcSEcCtD
Methimazole—Rash—Captopril—systemic scleroderma	0.00107	0.00337	CcSEcCtD
Methimazole—Dermatitis—Captopril—systemic scleroderma	0.00107	0.00336	CcSEcCtD
Methimazole—Somnolence—Lisinopril—systemic scleroderma	0.00107	0.00336	CcSEcCtD
Methimazole—Headache—Captopril—systemic scleroderma	0.00106	0.00334	CcSEcCtD
Methimazole—Dyspepsia—Lisinopril—systemic scleroderma	0.00106	0.00333	CcSEcCtD
Methimazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00105	0.00332	CcSEcCtD
Methimazole—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00331	CcSEcCtD
Methimazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00324	CcSEcCtD
Methimazole—Nausea—Captopril—systemic scleroderma	0.00101	0.00317	CcSEcCtD
Methimazole—CYP2C19—digestive system—systemic scleroderma	0.000997	0.0274	CbGeAlD
Methimazole—Pruritus—Leflunomide—systemic scleroderma	0.000988	0.00311	CcSEcCtD
Methimazole—CYP2B6—skin of body—systemic scleroderma	0.000976	0.0268	CbGeAlD
Methimazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000957	0.00302	CcSEcCtD
Methimazole—Urticaria—Lisinopril—systemic scleroderma	0.000953	0.003	CcSEcCtD
Methimazole—Body temperature increased—Lisinopril—systemic scleroderma	0.000948	0.00299	CcSEcCtD
Methimazole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000944	0.00297	CcSEcCtD
Methimazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000942	0.00297	CcSEcCtD
Methimazole—Vomiting—Azathioprine—systemic scleroderma	0.00094	0.00296	CcSEcCtD
Methimazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000934	0.00294	CcSEcCtD
Methimazole—Drowsiness—Methotrexate—systemic scleroderma	0.000933	0.00294	CcSEcCtD
Methimazole—Rash—Azathioprine—systemic scleroderma	0.000932	0.00294	CcSEcCtD
Methimazole—Dermatitis—Azathioprine—systemic scleroderma	0.000931	0.00293	CcSEcCtD
Methimazole—Headache—Azathioprine—systemic scleroderma	0.000926	0.00292	CcSEcCtD
Methimazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000925	0.00292	CcSEcCtD
Methimazole—Vomiting—Leflunomide—systemic scleroderma	0.000888	0.0028	CcSEcCtD
Methimazole—Alopecia—Prednisone—systemic scleroderma	0.000886	0.00279	CcSEcCtD
Methimazole—Rash—Leflunomide—systemic scleroderma	0.00088	0.00277	CcSEcCtD
Methimazole—Dermatitis—Leflunomide—systemic scleroderma	0.000879	0.00277	CcSEcCtD
Methimazole—Nausea—Azathioprine—systemic scleroderma	0.000878	0.00277	CcSEcCtD
Methimazole—Headache—Leflunomide—systemic scleroderma	0.000875	0.00276	CcSEcCtD
Methimazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000871	0.00275	CcSEcCtD
Methimazole—Pruritus—Lisinopril—systemic scleroderma	0.000849	0.00267	CcSEcCtD
Methimazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000847	0.00267	CcSEcCtD
Methimazole—Rash—Mycophenolic acid—systemic scleroderma	0.00084	0.00265	CcSEcCtD
Methimazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000839	0.00264	CcSEcCtD
Methimazole—Hepatitis—Methotrexate—systemic scleroderma	0.000838	0.00264	CcSEcCtD
Methimazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000835	0.00263	CcSEcCtD
Methimazole—Headache—Mycophenolic acid—systemic scleroderma	0.000834	0.00263	CcSEcCtD
Methimazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000831	0.00262	CcSEcCtD
Methimazole—Nausea—Leflunomide—systemic scleroderma	0.000829	0.00261	CcSEcCtD
Methimazole—CYP1A2—digestive system—systemic scleroderma	0.000815	0.0224	CbGeAlD
Methimazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000791	0.00249	CcSEcCtD
Methimazole—Vertigo—Prednisone—systemic scleroderma	0.000784	0.00247	CcSEcCtD
Methimazole—CYP2B6—digestive system—systemic scleroderma	0.000781	0.0215	CbGeAlD
Methimazole—CYP2C9—digestive system—systemic scleroderma	0.000773	0.0213	CbGeAlD
Methimazole—Vomiting—Lisinopril—systemic scleroderma	0.000763	0.0024	CcSEcCtD
Methimazole—Rash—Lisinopril—systemic scleroderma	0.000756	0.00238	CcSEcCtD
Methimazole—Dermatitis—Lisinopril—systemic scleroderma	0.000756	0.00238	CcSEcCtD
Methimazole—Headache—Lisinopril—systemic scleroderma	0.000751	0.00237	CcSEcCtD
Methimazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000744	0.00234	CcSEcCtD
Methimazole—Myalgia—Prednisone—systemic scleroderma	0.000743	0.00234	CcSEcCtD
Methimazole—Arthralgia—Prednisone—systemic scleroderma	0.000743	0.00234	CcSEcCtD
Methimazole—Alopecia—Methotrexate—systemic scleroderma	0.000741	0.00233	CcSEcCtD
Methimazole—CYP2E1—digestive system—systemic scleroderma	0.000733	0.0201	CbGeAlD
Methimazole—Nausea—Lisinopril—systemic scleroderma	0.000712	0.00225	CcSEcCtD
Methimazole—Oedema—Prednisone—systemic scleroderma	0.000712	0.00225	CcSEcCtD
Methimazole—CYP2E1—tendon—systemic scleroderma	0.000697	0.0192	CbGeAlD
Methimazole—CYP1A2—lung—systemic scleroderma	0.00068	0.0187	CbGeAlD
Methimazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000668	0.00211	CcSEcCtD
Methimazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000663	0.00209	CcSEcCtD
Methimazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000662	0.00209	CcSEcCtD
Methimazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000658	0.00208	CcSEcCtD
Methimazole—Vertigo—Methotrexate—systemic scleroderma	0.000655	0.00207	CcSEcCtD
Methimazole—Leukopenia—Methotrexate—systemic scleroderma	0.000653	0.00206	CcSEcCtD
Methimazole—CYP2B6—lung—systemic scleroderma	0.000652	0.0179	CbGeAlD
Methimazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000649	0.00205	CcSEcCtD
Methimazole—Paraesthesia—Prednisone—systemic scleroderma	0.00064	0.00202	CcSEcCtD
Methimazole—Dyspepsia—Prednisone—systemic scleroderma	0.000627	0.00198	CcSEcCtD
Methimazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000624	0.00197	CcSEcCtD
Methimazole—Myalgia—Methotrexate—systemic scleroderma	0.000621	0.00196	CcSEcCtD
Methimazole—Arthralgia—Methotrexate—systemic scleroderma	0.000621	0.00196	CcSEcCtD
Methimazole—CYP2E1—lung—systemic scleroderma	0.000612	0.0168	CbGeAlD
Methimazole—CYP3A4—digestive system—systemic scleroderma	0.00059	0.0162	CbGeAlD
Methimazole—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000583	0.00184	CcSEcCtD
Methimazole—CYP2D6—digestive system—systemic scleroderma	0.00058	0.016	CbGeAlD
Methimazole—Urticaria—Prednisone—systemic scleroderma	0.000566	0.00178	CcSEcCtD
Methimazole—Body temperature increased—Prednisone—systemic scleroderma	0.000563	0.00178	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000542	0.00171	CcSEcCtD
Methimazole—Paraesthesia—Methotrexate—systemic scleroderma	0.000535	0.00169	CcSEcCtD
Methimazole—Somnolence—Methotrexate—systemic scleroderma	0.000529	0.00167	CcSEcCtD
Methimazole—Dyspepsia—Methotrexate—systemic scleroderma	0.000524	0.00165	CcSEcCtD
Methimazole—Pruritus—Prednisone—systemic scleroderma	0.000504	0.00159	CcSEcCtD
Methimazole—Urticaria—Methotrexate—systemic scleroderma	0.000473	0.00149	CcSEcCtD
Methimazole—Body temperature increased—Methotrexate—systemic scleroderma	0.000471	0.00148	CcSEcCtD
Methimazole—Vomiting—Prednisone—systemic scleroderma	0.000453	0.00143	CcSEcCtD
Methimazole—Rash—Prednisone—systemic scleroderma	0.000449	0.00142	CcSEcCtD
Methimazole—Dermatitis—Prednisone—systemic scleroderma	0.000449	0.00141	CcSEcCtD
Methimazole—Headache—Prednisone—systemic scleroderma	0.000446	0.00141	CcSEcCtD
Methimazole—Nausea—Prednisone—systemic scleroderma	0.000423	0.00133	CcSEcCtD
Methimazole—Pruritus—Methotrexate—systemic scleroderma	0.000421	0.00133	CcSEcCtD
Methimazole—Vomiting—Methotrexate—systemic scleroderma	0.000379	0.00119	CcSEcCtD
Methimazole—Rash—Methotrexate—systemic scleroderma	0.000375	0.00118	CcSEcCtD
Methimazole—Dermatitis—Methotrexate—systemic scleroderma	0.000375	0.00118	CcSEcCtD
Methimazole—Headache—Methotrexate—systemic scleroderma	0.000373	0.00118	CcSEcCtD
Methimazole—Nausea—Methotrexate—systemic scleroderma	0.000354	0.00111	CcSEcCtD
